Becton Dickinson (BDX) Stock Forecast & Price Target

Compare

2,001 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

BDX Analyst Ratings

Moderate Buy

4 Buy

9 Hold

0 Sell

Based on 13 analysts giving stock ratings to

Becton

Dickinson

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

BDX Stock 12 Month Forecast

Average Price Target

$201.80

▲(18.73%Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Becton Dickinson in the last 3 months. The average price target is $201.80 with a high forecast of $255.00 and a low forecast of $172.00. The average price target represents a 18.73% change from the last price of $169.97.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"167":"$167","256":"$256","189.25":"$189.3","211.5":"$211.5","233.75":"$233.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":255,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$255.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":201.8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$201.80</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":172,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$172.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[167,189.25,211.5,233.75,256],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,168.38,175.0430769230769,181.70615384615385,188.36923076923077,195.03230769230768,201.69538461538463,208.35846153846154,215.02153846153846,221.68461538461537,228.3476923076923,235.01076923076923,241.67384615384617,248.33692307692309,{"y":255,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,168.38,170.95076923076923,173.52153846153846,176.09230769230768,178.66307692307691,181.23384615384614,183.80461538461537,186.37538461538463,188.94615384615386,191.5169230769231,194.08769230769232,196.65846153846155,199.22923076923078,{"y":201.8,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,168.38,168.65846153846152,168.93692307692308,169.2153846153846,169.49384615384616,169.7723076923077,170.05076923076922,170.32923076923078,170.6076923076923,170.88615384615383,171.1646153846154,171.44307692307692,171.72153846153847,{"y":172,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":228.33,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":226.62,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":224.87,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":231.48,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":237.76,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":238,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":231.67,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":219.44,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":224.49,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":245,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":224.68,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":168.52,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":168.38,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$255.00

Average Price Target$201.80

Lowest Price Target$172.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Travis SteedBank of America Securities

Bank of America Securities

―

Hold

―

Reiterated

06/09/25

Analysts Conflicted on These Healthcare Names: Innovent Biologics (Other OTC: IVBXF) and Becton Dickinson (NYSE: BDX)

Rick WiseStifel Nicolaus

Stifel Nicolaus

$224

Buy

31.79%

Upside

Reiterated

06/09/25

Stifel Nicolaus Sticks to Their Buy Rating for Becton Dickinson (BDX)

Matt MiksicBarclays

Barclays

$261→$241

Buy

41.79%

Upside

Reiterated

06/03/25

Becton Dickinson price target lowered to $241 from $261 at BarclaysBecton Dickinson price target lowered to $241 from $261 at Barclays

Joanne WuenschCiti

Citi

$217→$185

Hold

8.84%

Upside

Downgraded

05/23/25

Becton Dickinson downgraded to Neutral from Buy at CitiBecton Dickinson downgraded to Neutral from Buy at Citi

Patrick WoodMorgan Stanley

Morgan Stanley

$196

Buy

15.31%

Upside

Reiterated

05/23/25

Morgan Stanley Reaffirms Their Buy Rating on Becton Dickinson (BDX)

Andrew BrackmannWilliam Blair

William Blair

―

Hold

―

Downgraded

05/03/25

William Blair downgrades Becton Dickinson (BDX) to a Hold

Jayson BedfordRaymond James

Raymond James

―

Hold

―

Downgraded

05/02/25

Becton Dickinson downgraded to Market Perform from Outperform at Raymond JamesBecton Dickinson downgraded to Market Perform from Outperform at Raymond James

Robbie MarcusJ.P. Morgan

J.P. Morgan

$185

Hold

8.84%

Upside

Reiterated

05/02/25

J.P. Morgan Sticks to Its Hold Rating for Becton Dickinson (BDX)

David RomanGoldman Sachs

Goldman Sachs

$256→$192

Hold

12.96%

Upside

Downgraded

05/02/25

Analysts Offer Insights on Healthcare Companies: Align Tech (NASDAQ: ALGN), Evolus (NASDAQ: EOLS) and Becton Dickinson (NYSE: BDX)

Jason BednarPiper Sandler

Piper Sandler

$260→$185

Hold

8.84%

Upside

Downgraded

05/02/25

Becton Dickinson downgraded to Neutral from Overweight at Piper SandlerBecton Dickinson downgraded to Neutral from Overweight at Piper Sandler

Matthew TaylorJefferies

Jefferies

$305→$255

Buy

50.03%

Upside

Reiterated

05/01/25

Becton Dickinson's Resilience and Strategic Initiatives Drive Buy Rating Amid Market Challenges

Larry BiegelsenWells Fargo

Wells Fargo

$270→$172

Hold

1.19%

Upside

Reiterated

05/01/25

Becton Dickinson downgraded to Equal Weight from Overweight at Wells FargoBecton Dickinson downgraded to Equal Weight from Overweight at Wells Fargo

Josh JenningsTD Cowen

TD Cowen

$260→$183

Hold

7.67%

Upside

Reiterated

05/01/25

Becton Dickinson's Mixed Performance and Growth Challenges Justify Hold Rating

Vijay KumarEvercore ISI

Evercore ISI

$290→$275

Buy

61.79%

Upside

Reiterated

01/02/25

Becton Dickinson price target lowered to $275 from $290 at Evercore ISIBecton Dickinson price target lowered to $275 from $290 at Evercore ISI

David ToungArgus Research

Argus Research

$290

Buy

70.62%

Upside

Reiterated

11/21/24

Based on the updated guidance, we are raising our adjusted EPS estimate for fiscal 2025 to $14.42 from $14.20.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Travis SteedBank of America Securities

Bank of America Securities

―

Hold

―

Reiterated

06/09/25

Analysts Conflicted on These Healthcare Names: Innovent Biologics (Other OTC: IVBXF) and Becton Dickinson (NYSE: BDX)

Rick WiseStifel Nicolaus

Stifel Nicolaus

$224

Buy

31.79%

Upside

Reiterated

06/09/25

Stifel Nicolaus Sticks to Their Buy Rating for Becton Dickinson (BDX)

Matt MiksicBarclays

Barclays

$261→$241

Buy

41.79%

Upside

Reiterated

06/03/25

Becton Dickinson price target lowered to $241 from $261 at BarclaysBecton Dickinson price target lowered to $241 from $261 at Barclays

Joanne WuenschCiti

Citi

$217→$185

Hold

8.84%

Upside

Downgraded

05/23/25

Becton Dickinson downgraded to Neutral from Buy at CitiBecton Dickinson downgraded to Neutral from Buy at Citi

Patrick WoodMorgan Stanley

Morgan Stanley

$196

Buy

15.31%

Upside

Reiterated

05/23/25

Morgan Stanley Reaffirms Their Buy Rating on Becton Dickinson (BDX)

Andrew BrackmannWilliam Blair

William Blair

―

Hold

―

Downgraded

05/03/25

William Blair downgrades Becton Dickinson (BDX) to a Hold

Jayson BedfordRaymond James

Raymond James

―

Hold

―

Downgraded

05/02/25

Becton Dickinson downgraded to Market Perform from Outperform at Raymond JamesBecton Dickinson downgraded to Market Perform from Outperform at Raymond James

Robbie MarcusJ.P. Morgan

J.P. Morgan

$185

Hold

8.84%

Upside

Reiterated

05/02/25

J.P. Morgan Sticks to Its Hold Rating for Becton Dickinson (BDX)

David RomanGoldman Sachs

Goldman Sachs

$256→$192

Hold

12.96%

Upside

Downgraded

05/02/25

Analysts Offer Insights on Healthcare Companies: Align Tech (NASDAQ: ALGN), Evolus (NASDAQ: EOLS) and Becton Dickinson (NYSE: BDX)

Jason BednarPiper Sandler

Piper Sandler

$260→$185

Hold

8.84%

Upside

Downgraded

05/02/25

Becton Dickinson downgraded to Neutral from Overweight at Piper SandlerBecton Dickinson downgraded to Neutral from Overweight at Piper Sandler

Matthew TaylorJefferies

Jefferies

$305→$255

Buy

50.03%

Upside

Reiterated

05/01/25

Becton Dickinson's Resilience and Strategic Initiatives Drive Buy Rating Amid Market Challenges

Larry BiegelsenWells Fargo

Wells Fargo

$270→$172

Hold

1.19%

Upside

Reiterated

05/01/25

Becton Dickinson downgraded to Equal Weight from Overweight at Wells FargoBecton Dickinson downgraded to Equal Weight from Overweight at Wells Fargo

Josh JenningsTD Cowen

TD Cowen

$260→$183

Hold

7.67%

Upside

Reiterated

05/01/25

Becton Dickinson's Mixed Performance and Growth Challenges Justify Hold Rating

Vijay KumarEvercore ISI

Evercore ISI

$290→$275

Buy

61.79%

Upside

Reiterated

01/02/25

Becton Dickinson price target lowered to $275 from $290 at Evercore ISIBecton Dickinson price target lowered to $275 from $290 at Evercore ISI

David ToungArgus Research

Argus Research

$290

Buy

70.62%

Upside

Reiterated

11/21/24

Based on the updated guidance, we are raising our adjusted EPS estimate for fiscal 2025 to $14.42 from $14.20.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Becton Dickinson

1 Month

xxx

Success Rate

12/23 ratings generated profit

Average Return

+1.65%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 52.17% of your transactions generating a profit, with an average return of +1.65% per trade.

3 Months

xxx

Success Rate

10/23 ratings generated profit

Average Return

-1.89%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 43.48% of your transactions generating a profit, with an average return of -1.89% per trade.

1 Year

Rick WiseStifel Nicolaus

Success Rate

9/23 ratings generated profit

Average Return

-3.92%

reiterated a buy rating 18 days ago

Copying Rick Wise's trades and holding each position for 1 Year would result in 39.13% of your transactions generating a profit, with an average return of -3.92% per trade.

2 Years

xxx

Success Rate

11/23 ratings generated profit

Average Return

-2.83%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 47.83% of your transactions generating a profit, with an average return of -2.83% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BDX Analyst Recommendation Trends

Rating

Jan 25

Feb 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, BDX has received 8 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. BDX average Analyst price target in the past 3 months is 201.80.

Each month's total comprises the sum of three months' worth of ratings.

BDX Financial Forecast

BDX Earnings Forecast

Next quarter’s earnings estimate for BDX is $3.42 with a range of $3.36 to $3.50. The previous quarter’s EPS was $3.35. BDX beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.14% of the time in the same period. In the last calendar year BDX has Outperformed its overall industry.

BDX Sales Forecast

Next quarter’s sales forecast for BDX is $5.49B with a range of $5.47B to $5.54B. The previous quarter’s sales results were $5.27B. BDX beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.46% of the time in the same period. In the last calendar year BDX has Outperformed its overall industry.

BDX Stock Forecast FAQ

What is BDX’s average 12-month price target, according to analysts?

Based on analyst ratings, Becton Dickinson And Company’s 12-month average price target is 201.80.

What is BDX’s upside potential, based on the analysts’ average price target?

Becton Dickinson And Company has 18.73% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is BDX a Buy, Sell or Hold?

Becton Dickinson And Company has a consensus rating of Moderate Buy which is based on 4 buy ratings, 9 hold ratings and 0 sell ratings.

What is Becton Dickinson And Company’s price target?

The average price target for Becton Dickinson And Company is 201.80. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $255.00 ,the lowest forecast is $172.00. The average price target represents 18.73% Increase from the current price of $169.97.

What do analysts say about Becton Dickinson And Company?

Becton Dickinson And Company’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of BDX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Becton Dickinson (BDX) Stock Forecast & Price Target

BDX Analyst Ratings

BDX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Becton Dickinson

BDX Analyst Recommendation Trends

BDX Financial Forecast

BDX Earnings Forecast

BDX Sales Forecast

BDX Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts